Aysu Say, Betiil Acunag, h e r Ceran P e d i a t r i c Department o f Zeynep Kamil H o s p i t a l , I s t a n b u l . Turkey The aim or t h i s study was to diagnose Neonatal Se11ticc1111a by determining serum prealbumin l e v e l s a s a negative acuLe ~>lwse r e a c t a n t and serum 82 microglobulin c o n c e n t r a t i o n s , a q u e s t i o l u ble acute lhase r e a c t a n t . Twenty healthy r1ewbol.11 bilblcs a s the c o n t r o l group and 20 term newborn babics with r l l t l c e l n i a were i n c l u d e d i n t k study. Serum c m c e n t r a t i o n o f realbu bum in showed a s i g n i f i c a n t (p < 0,001) decrease i n t l r s e p s i s group compared with the c o n t r o l group. It had a s e n s i v i t y r a t e of L 85, s l~e c i f i t y r a t e of % 95, p o s i t i v e p r e d i c t i v e value of Z 94 aid n c g a t i v e p r e d i c t i v e value of % 91. Serum $ 2 -m i c r o g l u b u l i~~ levels were s i g n i f i c a n t l y ( p < 0,001) higher i n the s e p s i s group than i l l Lhe c o n t r o l group, yet i t had lower s e n s i v i t y , s p e c i f i t y irrld [~o s i t i v e , negative p r e d i c t i v e values compared with Ule ,;realbwitin values. r e s p e c t i v e l y % 65. % 90. % 86 a r~d X 72. Since serum preal bun~in assay is an m s i l y -e s t a b l i s h e d and r e l i a b l e t e s t , we cunclude t h a t serunl prealbumin determination can be an iiiiporLant n i t i n the d i a g n o s i s of neonatal septicemia.
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BENZATHINE PENICILLIN I N ALVEOLAR LOBAR AND SEGMENTAL PNEUMONIA: a c o n t r o l l e d c l i n i c a l t r i a l ( * ) Paulo Camargos.Mark Guimaraes,Cid F e r r e i r a ( s p n . b y Prof.
114 G . Duc) ,Universidade Federal de Minac G e r a i s , B r a z i l .
Objective: t o a s s e s s the e f f i c a c y of benzathine p e n i c il l i n ( U P ) f o r t r e a t i n g presumedly pneumococcal n l v e u l d r lobar/segmental pneumonia(ALSP)as compared t o procaine p e n i c i l l i n ( P P ) , i n Belo Horizonte, Minas C e r a i s S t a t e , B r a z i l . Methods: c r i t e r i a i n c l u s i o n were a)2-12 y e a r s o l d , b ) c l i n i c a l and r a d i o l o g i c a l d i a g n o s i s of ALSP,c)no p r i o r a n t i b i o t i c and d ) n o sev e r e concomitant disease.The BP and PP t r e a t m e n t s were randomized i n two groups and t h e regimens were one s i n g l e dose o r 81' and seven days o f PP.Efficacy was assessed by c l i n i c a l and r a d i o l o g i c a l improvement i n t h e 7 t h and/or 14th day a f t e r admission.'l'he i n t e rp r e t a t i o n of c h e s t f i l m s were made i n a b l i n d n e s s f a s h i o n .
S t a t i st i c a l a n a l y s i s included t h e F i s c h e r ' s Exact T e s t ( s i g n . l c v c l : . O 5 ) .
Results:116 p a t i e n t s had been included i n the study;63(54,3X)were a l l o c a t e d t o BP and 53(45,7%)to PP groups. 90,5% of the p .~t i e n t s i n tlie BP group and 94.3% i n t h e YP group presented c l i r i i c u l and r a d i o l o g i c ilnprovements(p=.505). Conc1usions:a)BP treatment was a s e l f i c a c i o u s a s t'iJ t r c a t n t e~~t f o r ALSP i n t h i s study;b)due t o high morbidity and m o r t a l i t y o t pneumonia i n the Third World,thc low c o s t and e x c e l l e n t compliilncc o f B P , t h i s regimen may be an important a l t e r n a t i v e f o r i n t e r n a t i o n a l l y accepted PP regirnen;c)morc p r e c i s e e s t i m a t e s with improved p o i e r w i l l be generated by higher numbers a s the study continues. *supported by FINEP(Studies and P r o j e c t s Financing Agcncy),Urazil There is a sufficient amount of data that TNF-alpha, the monokine produced by macro liages after bacterial stimulation mi 1111 be a n import:tnt actor responsible f ! r 'irreversible tissue damage durin hic septic shock. In a n attempt t o elucidate the ossible function of T N F -: &~~ in the pathomechanism of sepsis t i e aisesment of TNF-alpha activity in the blood of newborns with bacterial septicaemia was performed. A sample of 21 newborns with se sis 13 with Staph.epi., 1 with Staph.aur., 7 with G(-) bacteria) was stufi;d. inxeasing use of invasive praxdures, antibiotic and imrmnanppressive t . r e a m has caused an increase in candidal infections which has led to a search for new a n t i f 9 1 w. In our earlier studies ( 1 ) ketoconazole ( k e t o ) , an oral antifungal agent, p m e d not to be useful in pretenrs. The absorption of keto w a s probably prevented due to a d i n a t i o n of low gastric acidity and continuous gavage feeding. We now invgtigated the bioavailability of itramzole (itra), also an oral antifungal agent with brcad s p c t r m activity and low toxicity, in preterm infants with a postconceptio~l age below 32 weeks. Trmgh and peak senrm levels of itra (P.51211) and its metablite (R63373) were measured in 5 preterm infants 48h after initiating therapy with a dcse of 5 q p g of itra in hydroxypmpyl-beta-cycl~in solution by HPU-assay. itra R63373 level(ng/ml) 28-264 85-588 peak level (ng/ml)
129-547 178-660
We m l u r l e that (2) itra is well ahsorbed and reoommended levels are reached. No side effects of itra were seen. It m y be a useful antifup1 drug in pretenm, h t further studies on efficacy and safety are needed. The effects of cbz-leucine-tyrosine-chioromethylketone(zLYCK). an inhibitor of chymotrypsin, were investigated in the activation pathways of human neutrophil respiratory burst. At 10 pM zLYCK showed a parallel inhibition of superoxide productioll stimulated with the chemoattractant lormyl-methionyl-leucyl phenylalanine (FMLP) and chymotrypsin-like activity of human neutrophils. By contrast superoxide production induced by phorbol mirystate acetate (PMA) was minimally affected by zLYCK. The known transduction pathways triggered by FMLP were analyzed zLYCK did not affect either FMLP-induced cytosolic free calcium transient, inositol 1.4,s triphosphate formation nor the PMA-induced phosphorylation of the 47 kD substrate of protein kinase c zLYCK did not allect the activity of protein kinase c extracted from neutrophlls. The activity of the NADPH oxldase tested with active membranes from stimulated neutrophils or in a cell-free-system was not inhibited by zLYCK. We conclude that 1) zLYCK inhibits superoxide production through the inhibition of a chymotrypsin-like protease of the neutrophil 2) zLYCK Inhibits FMLP-induced activation of NADPH oxidase through a pathway independent of PtdlnsP breakdwon and cytosol~c free calcium 3) zLYCK may prove an useful p r k e for the characterization of its target protease in neutrophil activation. cherichia Cali JS vaccine was shown to decrease the mortality from Gramnegative shock. We analyzed the effect of anti-J5 plasma on the course and mortality of severe infectious purpura. Patients with a clinical diagnosis of sepsis wiwth purpuric lesions were enrolled if they were in shock. They received either anti-JS plasma or control plasma. Before the administration of the plasma, 6 hours after and after 5 days of evolution, serum levels of anti-JS antibodies. tumor necrosis faclor alpha (TNF), interleukin-6 (IL-6) and elastase-al-anliprotease complexes were determined. 73 patients were randomized, 40 in the anti-JS and 33 in the control group. Clinical and biological risk factors were siniilnr in the two groups. However, TNF serum concentrations were 974?173pg/ml versus 473r85pg/mI. (p=0.023) and IL-6 serum concentrations were 129i45 versus 19tSng/rni (p=0.005) in the control group and in the treated group respectively. The diration of hypotension of vasopressor therapy and of respiratory assistance and the occurrence' of systemic complications were similar in the 2 groups. The mortality rate was 36 % in the control group and 25% in the treated group (p=0.317) (risk ratio:0.58;95% confidence interval:0.19-1.79). This trend disappeared after correction for imbalances at randomization using a logistic regression model. Anti-JS plasma did not change the course and the mortality of severe infectious purpura in children.
